Legislative/Regulatory
The Delaware Healthcare Association comments on a number of health care-related legistive & regulatory issues on behalf of its member hospitals and health systems.
FSHLA Joint Letter to Highmark Delaware Regarding Provider Relations
Delaware Health Leaders Issue Joint Letter to Highmark
DHA Comments Board of Pharmacy (SB 180)
Joint Letter – HB 153
Joint Letter – Support of House Bill 215
DHA Supporting Comments Overpayment Recovery and Audit Practice (HB 212)
DHA Comments Respiratory Care Practitioners (SB 94)
DHA Supports Pre-Authorization Reform (SB 12)
DHA Comments Diabetes Wellness Pilot Program (HS 1 for HB 163)
DHA Supporting Comments for Healthcare Services Protections (HB 205)
DHA Supporting Comments Voluntary Admissions (SB 152)
DHA Letter to U.S. Senate on HR 1
No results found.